Fluidigm’s Covid-19 Saliva Test Receives Emergency FDA Authorization
Hologic Snaps Up Fibroid Specialist Acessa For $80M; BTIG Bullish
WVU-led study aims to identify, relieve anxiety and depression caused by COVID-19
Medtronic Gains 4% As Quarterly Profit Tops Estimates Amid Faster Recovery
HCQ All Over Again: WaPo Trashes Blood Plasma COVID-19 Treatment After Trump Announces Breakthrough
Sequoia, General Atlantic Said To Push Oracle Bid For TikTok - Report
Editas Scores Rare Disease Tag For EDIT-301 Sickle Cell Treatment
Flexible targets help immune system make finely-tuned antibodies
2 Healthcare Stocks Under $5 That Could Deliver Triple-Digit Gains
I'm a lung doctor testing the blood plasma from COVID-19 survivors as a treatment for the sick – a century-old idea that could be a fast...
Billionaire Jim Simons Bets on These 2 "Strong Buy" Stocks
Merck Wins 2 Approvals For Keytruda Therapy In Japan
Sonnet Bio Spikes 70% In Pre-Market On FDA Covid-19 Plasma Nod
Oregon May Soon Decriminalize Low-Level Possession Of All Drugs, Massively Reducing Arrests
Morgan Stanley Is Getting Bullish About Biotech; Here Are 2 Stocks to Buy
Gilead Says FDA Could Broaden Remdesivir Use Despite Data; Analyst Slashes PT
Gilead remdesivir study finds only marginal benefit for moderate Covid-19 patients
Harvard’s Wyss Institute launches Torus Biosystems
Oppenheimer Says These 2 Stocks Could Surge Over 100% From Current Levels
I'm a lung doctor testing the blood from COVID-19 survivors as a treatment for the sick – a century old idea that could be a fast...
Coronavirus pharma news round-up 21/08/20
Pilot study backs Kaia Health app for back pain relief
AstraZeneca’s Imfinzi Wins Japan Approval For Small Cell Lung Cancer
FDA Approves New Kyprolis Combination Regimen
A potential new weapon in the fight against COVID-19: Food coloring
Patient-to-Patient Supply for Cell Immunotherapies Summit
Why face masks can make eyes feel dry, and what you can do about it
CytoDyn Seeking UK Fast-Track Approval For Leronlimab In Covid-19
These 2 Beaten-Down Stocks Are Poised to Bounce Back, Say Analysts
AstraZeneca Gets FDA Priority Review For New Dose Of Imfinzi Cancer Drug